合成目标产物 Trans-4-Hydroxy-L-Proline Methyl Ester Hydrochloride 主要起始原料 Methanol And Boc-Hyp-Oh
(文献来源)合成步骤主要原料 Methanol 和 Boc-Hyp-Oh
N-Boc-反式-4-羟基-L-脯氨酸甲酯置于盐酸体系中,用 1,4-二氧六环 作为反应溶剂,化学反应 3.0H,反应生成 反式-4-羟基-L-脯氨酸甲酯盐酸盐 参考文献:Pyrrole Compounds As Granzyme B Inhibitors 标题:Pyrrole Compounds As Granzyme B Inhibitors 摘要:吡咯化合物作为粒酶b抑制剂,包括这些化合物的组合物以及使用这些化合物的方法.提供了一种治疗皮肤硬化病,大疱性表皮松解症,放射性皮炎,斑秃和蝶形红斑狼疮的方法.
专利号:US-8829184-B2 优先权日:2010-04-15 标题:Intermediates useful for the synthesis of pyrrolobenzodiazepines 发明人:HOWARD PHILIP WILSON; MASTERSON LUKE; TIBERGHIEN ARNAUD 权利人:HOWARD PHILIP WILSON; MASTERSON LUKE; TIBERGHIEN ARNAUD; SPIROGEN SARL 摘要:A compound of formula (I): which is substantially free of any of the corresponding compound of formula (IB): methods of making such compounds, and the further transformation of such compounds.
专利号:US-2012095211-A1 优先权日:2010-09-22 标 题 :Substituted proline inhibitors of hepatitis c virus replication 发明人:BUCKMAN BRAD; NICHOLAS JOHN B; SEREBRYANY VLADIMIR; SEIWERT SCOTT D 权利人:BUCKMAN BRAD; NICHOLAS JOHN B; SEREBRYANY VLADIMIR; SEIWERT SCOTT D; INTERMUNE INC 摘要:The embodiments provide compounds of the general Formulae I, Ia, II, IIa, III, IIIa, IIIb, IV, IVa, IVb, V, Va, Vb, VI, VIa, VIb, and VIc, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition. The embodiments also provide methods for the synthesis of subject compounds and intermediates in the synthetic methods.
专利号:US-2024124938-A1 优先权日:2019-10-16 标题:Visual detection of pbd induced dna crosslinks 发明人:LACHAUD CHRISTOPHE; COMBES SÉBASTIEN; ABEL SÉBASTIEN; AUDOLY GILLES; BERRADA SARA 权利人:INST NAT SANTE RECH MED; INST JEAN PAOLI & IRENE CALMETTES; AIX MARSEILLE UNIV; CENTRE NAT RECH SCIENT 摘要:The present invention relates to the field of oncology. laboratory tools and methods, and especially anti-tumor DNA crosslinking agents. Most patients with advanced solid tumors develop resistance to chemotherapy due to the ability of cancer cells to repair or tolerate sustained DNA damages. The inventors showed that the compounds according to the present invention allow the detection and visualization of alkylated DNA damages induced by PBDs without altering their DNA crosslinking ability. This enables the study of the effect and properties of PBDs. In particular, the present invention relates new derivates of PBD molecules and their synthesis. The present invention also relates to a method for visualizing DNA crosslinking: to a method for assessing the resistance of a tumor to a crosslinking agent and to a method for identifying a molecule or treatment for improving the efficiency of a crosslinking agent.
专利号:US-2013035484-A1 优先权日:2010-04-15 标 题:Intermediates useful for the synthesis of pyrrolobenzodiazepines
专利号:CN-109957566-B 优先权日:2017-12-26 标 题 :Modified oligonucleotides and compounds useful in the synthesis of modified oligonucleotides
专利号:CN-109957566-A 优先权日:2017-12-26 标 题 :Modified oligonucleotides and compounds useful in the synthesis of modified oligonucleotides
[参考文献]: Beck A, Et Al. Strategies And Challenges For The Next Generation Of Antibody-Drug Conjugates. Nat Rev Drug Discov. 2017;16(5):315-337. [参考文献]: Nalawansha Da, Et Al. Protacs: An Emerging Therapeutic Modality In Precision Medicine. Cell Chem Biol. 2020;27(8):998-985.
合成参考文献
参考文献:10.1186/s40508-015-0039-0 摘要:Müller CR, Rosen A, Domínguez de María P. Multi-step enzyme-organocatalyst C–C bond forming reactions in deep-eutectic-solvents: towards improved performances by organocatalyst design. Sustainable Chemical Processes. 2015 Aug 12;3(1):12. doi: 10.1186/s40508-015-0039-0.